From pharma at jsbintelligence.com  Tue May 10 18:55:17 2005
From: pharma at jsbintelligence.com (pharma@jsbintelligence.com)
Date: Tue May 10 18:55:26 2005
Subject: [Rd] Re: 80-page Pharma complimentary report-Emerging Business
	models in Pharma (PR#7847)
Message-ID: <20050510165517.2562FE18C@slim.kubism.ku.dk>

------=_NextPart_84815C5ABAF209EF376268C8
Content-type: text/plain; charset=ISO-8859-1


Hello! 

This is just a quick note to inform you about an 80-page report on the Pharmaceutical Industry that we're able to provide you - at no cost. 

Compiled by some of the best analysts in the industry, the report provides an insight into the latest trends and strategies in the Pharmaceutical Industry. Over 50 pharma and biotech companies have been interviewed and benchmarked, and the resulting analysis will give you a comprehensive look at the future of the Industry. 

Maybe you haven't heard this yet - but Pharma companies are going through some huge changes in response to activities such as parallel trade, generic vs. patent fight, mergers and acquisitions, in-licensing and out-licensing, and the choice between semi block buster and block buster model. The report not only analyses the large structural changes and dynamic shifts in the Industry, it also takes an in-depth look at new revenue models. Another area of analysis is the shift from chemical-based small molecules to biology-based large molecules like antibodies and protein, and what new opportunities this has created in the Industry. 

To download the full report and view the table of contents click here. http://www.jsbintelligence.com/template.asp?docId=22&docName=Pharma-Report-Form

Should you be the wrong person to contact for this type of report, we would greatly appreciate if you would forward this email to the appropriate person in your company. 
Please do not hesitate to contact us shall you have any questions. 

Regards,
The JSB Intelligence Team 
www.jsbintelligence.com


    http://www.benchmarkemail.com/link/unsubscribe.asp?g=0&c=43101&l=37437901&e=r-bugs@biostat.ku.dk Click here  to unsubscribe from our mailing list. Or  reply to this message with the word unsubscribe or remove in the subject line.   

Address : Kildare House, 102-104 Sheen Road City: London  St: Outside US  Zip: TW9 1UF

Powered by Benchmarkemail
http://www.benchmarkemail.com 

REPORT ABUSE
http://www.benchmarkemail.com/link/report_abuse.asp?g=0&c=43101&l=37437901&e=r-bugs@biostat.ku.dk

------=_NextPart_84815C5ABAF209EF376268C8
Content-Type: text/html; charset=ISO-8859-1

<P><FONT face=Arial size=2> </FONT></P>
<P><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Arial">Hello! </SPAN></P>
<P><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Arial">This is just a quick note to inform you about an 80-page report on the Pharmaceutical Industry that we're able to provide you - at no cost. </SPAN></P>
<P><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Arial">Compiled by some of the best analysts in the industry, the report provides an insight into the latest trends and strategies in the Pharmaceutical Industry. Over 50 pharma and biotech companies have been interviewed and benchmarked, and the resulting analysis will give you a comprehensive look at the future of the Industry. </SPAN></P>
<P><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Arial">Maybe you haven't heard this yet - but Pharma companies are going through some huge changes in response to activities such as parallel trade, generic vs. patent fight, mergers and acquisitions, in-licensing and out-licensing, and the choice between semi block buster and block buster model. The report not only analyses the large structural changes and dynamic shifts in the Industry, it also takes an in-depth look at new revenue models. Another area of analysis is the shift from chemical-based small molecules to biology-based large molecules like antibodies and protein, and what new opportunities this has created in the Industry. </SPAN></P>
<P><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Arial"><A href="http://www.benchmarkemail.com/link/redirect.asp?g=0&c=43101&l=37437901&e=r-bugs@biostat.ku.dk&url=http://www.jsbintelligence.com/template.asp?docId=22&docName=Pharma-Report-Form">To download the full report and view the table of contents click here.<SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 'Times New Roman'"><?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></A></SPAN></P>
<P><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Arial">Should you be the wrong person to contact for this type of report, we would greatly appreciate if you would forward this email to the appropriate person in your company. </SPAN></P>
<P><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Arial">Please do not hesitate to contact us shall you have any questions. </SPAN></P>
<P><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: Arial">Regards,<BR>The JSB Intelligence Team <BR><A href="http://www.benchmarkemail.com/link/redirect.asp?g=0&c=43101&l=37437901&e=r-bugs@biostat.ku.dk&url=http://www.jsbintelligence.com/">www.jsbintelligence.com</A></SPAN></P>
<center><font color=#000000 size='1' face='Arial' >   <a href="http://www.benchmarkemail.com/link/unsubscribe.asp?g=0&c=43101&l=37437901&e=r-bugs@biostat.ku.dk">Click here</a> to unsubscribe from our mailing list. Or <br> reply to this message with the word unsubscribe or remove in the subject line.  &nbsp; 

 <img src=http://www.benchmarkemail.com/link/open.asp?g=0&c=43101&l=37437901&f=0 border=0 height=1 width=1> &nbsp;
 </font></center>
<center><font color=#000000 style='font-size:7pt;font-family:Verdana;'>Address : Kildare House, 102-104 Sheen Road City: London  St: Outside US  Zip: TW9 1UF </font></center><br><br><center><a href="http://www.benchmarkemail.com" target=benchmarkemail><font color=#c0c0c0 face='Verdana,Arial' style='font-size:8pt;text-decoration:underline' ><b>Powered by Benchmarkemail</b></font></a></center><br><center><a href="http://www.benchmarkemail.com/link/report_abuse.asp?g=0&c=43101&l=37437901&e=r-bugs@biostat.ku.dk" target=benchmarkemail><font color=#C0C0C0 face='Verdana,Arial' style='font-size:8pt;text-decoration:underline' ><b>REPORT ABUSE</b></font></a></center></body></html>
------=_NextPart_84815C5ABAF209EF376268C8--


[Rd] Re: 80-page Pharma complimentary report-Emerging Business models in Pharma (PR#7847)
pharma@jsbintelligence.com